Inflation and declining FDA drug approvals will pose challenges for pharma contract manufacturers in 2023, says GlobalData
FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop
FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop
New York State’s largest health system adopts Philips patient monitoring platform to drive integration and innovation for a better patient and staff experience and improved outcomes
The summit encompasses multiple verticals, spanning from pharmaceuticals, biotech, life sciences, and the Healthcare sector to ensure an unbiased and comprehensive view on the future of the function.
China is among the top countries reporting a high number of diagnosed prevalent cases for gastric, breast, and bladder cancers among the 16 major markets
SCYNEXIS will receive an upfront payment of $90 million with future performance-based milestone payments and tiered royalties
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
70+ CXOs from leading healthcare institutions across India attended the confluence at Mumbai
Licences should enable potentially millions of people living in areas most impacted by HIV to access this innovative prevention medicine through low-cost generic manufacturers
States advised to undertake mock drills to ensure operational readiness of Hospital Infrastructure including Oxygen Cylinders, PSA plants, ventilators and human resources
Subscribe To Our Newsletter & Stay Updated